Vanguard Capital Management’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126K Hold
124,591
– – ﹤0.01% 3828
2026
Q2
$154K Hold
124,591
– – ﹤0.01% 3840
2026
Q1
$151K Buy
+124,591
New +$156K ﹤0.01% 3828

Other funds holding BCDA

Vanguard Capital Management's BCDA Position: Q3 2026 in Review

Vanguard Capital Management held its BioCardia (BCDA) position steady in Q3 2026 at 124,591 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.

Vanguard Capital Management first reported a position in BCDA in Q1 2026 and has held it in 3 quarters since. The position peaked at $154K in Q2 2026. 18 funds tracked by Wall St. Rank hold BCDA as of Q3 2026.

  • Vanguard Capital Management held 124,591 shares of BioCardia worth $126K as of Q3 2026.
  • Vanguard Capital Management left its BioCardia share count unchanged in Q3 2026.
  • BioCardia made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3828 holding.
  • Vanguard Capital Management first reported a position in BioCardia in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's BioCardia position peaked at $154K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.